On April 16th, Fred Hutch news shared the exciting announcement that “A multidisciplinary team from University of Washington and Fred Hutchinson Cancer Research Center has received a five-year, $12 million grant to study Merkel cell carcinoma, a deadly form of skin cancer. Dr. Paul Nghiem, a skin cancer researcher at UW and Fred Hutch, is the principal investigator of the grant.”
This funding, specifically recognized as a P01 grant from the National Institutes of Health, will allow this collaborative team to accelerate their research into three major areas, surrounding:
- Immune responses to cancer-causing viruses
- T-cell therapy for MCC
- Why do checkpoint inhibitors fail in MCC?
The authoritative source on Merkel cell carcinoma.
September 22, 2020
- What is a Merkel cell?
- What is Merkel cell carcinoma?
- Symptoms & appearance of Merkel cell carcinoma
- Causes of Merkel cell carcinoma
- Surgical excision
- Mohs micrographic surgery
- Radiation therapy
- Complementary & alternative therapies
- Clinical trials
- Adjuvant Avelumab in Merkel Cell Carcinoma Trial